Meeting
2017 ASCO Annual Meeting
Prognostic impact of tumor budding in stage II colon cancer: A prospective study (SACURA trial).
Authors
Hideki Ueno
National Defense Medical College, Department of Surgery, Saitama, Japan
Hideki Ueno , Megumi Ishiguro , Eiji Nakatani , Toshiaki Ishikawa , Hiroyuki Uetake , Kenta Murotani , Shigeyuki Matsui , Naohiro Tomita , Yasuhiro Shimada , Keiichi Takahashi , Kenjiro Kotake , Masahiko Watanabe , Hidetaka Mochizuki , Satoshi Teramukai , Kenichi Sugihara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Clinical Trial Registration Number
NCT00392899
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3609)
DOI
10.1200/JCO.2017.35.15_suppl.3609
Abstract #
3609
Poster Bd #
232
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Factors influencing the number of retrieved lymph nodes (LNs) in patients with stage II colon cancer: LN size and areas of B cells and T cells.
First Author: Kazutake Okada
Poster
2023 ASCO Annual Meeting
The number of lymph nodes examined as a poor prognosis factor in stage II and stage III colon cancer patients undergoing curative surgery.
First Author: JEONGSEOK JEON
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prognostic value of tumor budding in patients with stage II and III colon cancer: A single-institution experience.
First Author: David Viñal
Poster
2021 ASCO Annual Meeting
JCOG1805 (PanDRa-BD study): A randomized controlled study of adjuvant chemotherapy for stage II colorectal cancer patients at high-risk of developing recurrence according to T-stage and three selected pathological factors (Pn, DR, and BD).
First Author: Megumi Ishiguro